Medifast Cash Flow - Quarterly (NYSE:MED)

Add to My Stocks
$154.81 $0.51 (0.33%) MED stock closing price Jun 22, 2018 (Closing)

The financial analysis of MED requires an investor to check the cash flows for Medifast. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Medifast profits and Medifast debt. This statement can tell if a company is running out of money while still being profitable and is useful in Medifast stock analysis. Medifast had a positive net income cash flow of $12.22M till this quarter of 2018 Q1. This report is very useful in measuring the short term viability of a company. Medifast has a positive cash and cash equivalents change of $11.88M.

View and download details of Medifast cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
12.22M27.72M20.41M13.72M6.14M17.83M13.72M7.65M4.26M20.05M
Depreciation Depletion Amortization Cash-Flow1.69M4.91M3.75M2.49M1.07M5.4M4.21M2.99M1.6M7.11M
Net Increase (Decrease) in Assets Liabilities3.11M6.78M6.49M2.86M-1.45M-4.23M3.28M4.1M1.94M3.84M
Cash From (used in) Discontinued Operations------0.64M-0.47M-0.27M--4.2M
Other Adjustments Net-3.82M2.59M1.66M-6.98M4.92M4.23M-0.17M2.59M
Net Cash from (used by) Operating Activities
18M43.23M33.25M20.74M6.68M25.35M25.66M18.72M7.66M29.41M
Increase (Decrease) in Prop Plant And Equipment-1.28M-3.16M-2.32M-0.96M-0.41M-2.2M-1.36M-0.09M--2.81M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments1.2M--1.05M-0.74M-0.6M--4.3M-2.63M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
-0.08M-3.16M-3.37M-1.71M-1.01M-2.03M-1.2M4.21M1.2M-0.18M
Issuance (Purchase) of Equity Shares-0.15M-1.97M-0.26M-0.25M-0.25M-1.04M-0.44M-0.44M-0.67M-11.76M
Issuance (Repayment) of Debt Securities------0.21M-0.16M-0.1M-0.05M-0.25M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions-5.88M-15.39M-11.51M-7.69M-3.87M-11.88M-8.89M-5.92M-2.96M-
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
-6.03M-17.36M-11.77M-7.94M-4.13M-12.92M-9.39M-6.37M-3.6M-11.73M
Effect of Exchange Rate Changes on Cash--0.07M--------
Net Change in Cash & Cash Equivalents
11.88M22.64M18.11M11.09M1.53M10.39M15.08M16.57M5.27M17.57M
Cash & Equivalents at Beginning of Year52.43M42.03M24.45M36.38M39.93M14.26M17.16M10.6M1.84M2.19M
Cash & Equivalents at Year End86.96M75.07M70.55M63.53M53.97M52.43M57.12M58.61M47.31M42.03M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Medifast stock price history and Medifast stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Medifast is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Medifast stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Medifast gained $18M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: Medifast used $-0.08M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-6.03M for Medifast.

Key Financial Ratios For Medifast Cash Flow

FCF margin
0.17